EUVIMEDEUVIMED entdecken
Open Access

MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming

Shashi Anand, Mohammad Aslam Khan, Haseeb Zubair iD, Sarabjeet Kour Sudan, Kunwar Somesh Vikramdeo, Sachin Kumar Deshmukh, Shafquat Azim, Sanjeev Kumar Srivastava, Seema Singh, Ajay Pratap Singh iD

EMBO Reports · 06.03.2023 · 24 (3)

DOI: 10.15252/embr.202255643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMBO Reports, online erschienen am 02.01.2023. Verfasst von Shashi Anand und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extensive desmoplasia and poor vasculature renders pancreatic tumors severely hypoxic, contributing to their aggressiveness and therapy resistance. Here, we identify the HuR/MYB/HIF1α axis as a critical regulator of the metabolic plasticity and hypoxic survival of pancreatic cancer cells. HuR undergoes nuclear-to-cytoplasmic translocation under hypoxia and stabilizes MYB transcripts, while MYB transcriptionally upregulates HIF1α. Upon MYB silencing, pancreatic cancer cells fail to survive and adapt metabolically under hypoxia, despite forced overexpression of HIF1α. MYB induces the transcription of several HIF1α-regulated glycolytic genes by directly binding to their promoters, thus enhancing the recruitment of HIF1α to hypoxia-responsive elements through its interaction with p300-dependent histone acetylation. MYB-depleted pancreatic cancer cells exhibit a dramatic reduction in tumorigenic ability, glucose-uptake and metabolism in orthotopic mouse model, even after HIF1α restoration. Together, our findings reveal an essential role of MYB in metabolic reprogramming that supports pancreatic cancer cell survival under hypoxia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsMiceAnimalsHypoxiaPromoter Regions, GeneticCell HypoxiaCell Line, TumorHypoxia-Inducible Factor 1, alpha Subunit

Stichwörter der Autor:innen

HIF1αMYBhypoxiametabolic reprogrammingpancreatic cancer

Substanzen

Hypoxia-Inducible Factor 1, alpha Subunit

Autor:innen und Institutionen

  • Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, USA.
  • Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
  • Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL, USA.

ORCID-Profile: Haseeb Zubair, Ajay Pratap Singh

Förderung

  • NCI NIH HHS
  • HHS | NIH | National Cancer Institute

Zitieren

APA

Anand, S., Khan, M. A., Zubair, H., Sudan, S. K., Vikramdeo, K. S., Deshmukh, S. K., Azim, S., Srivastava, S. K., Singh, S., & Singh, A. P. (2023). MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. EMBO Reports, 24(3). https://doi.org/10.15252/embr.202255643

Vancouver

Anand S, Khan MA, Zubair H, Sudan SK, Vikramdeo KS, Deshmukh SK, et al. MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. EMBO Reports. 2023;24(3). doi:10.15252/embr.202255643

BibTeX
@article{Anand2023,
  author = {Anand, Shashi and Khan, Mohammad Aslam and Zubair, Haseeb and Sudan, Sarabjeet Kour and Vikramdeo, Kunwar Somesh and Deshmukh, Sachin Kumar and Azim, Shafquat and Srivastava, Sanjeev Kumar and Singh, Seema and Singh, Ajay Pratap},
  title = {MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming},
  journal = {EMBO Reports},
  year = {2023},
  volume = {24},
  number = {3},
  doi = {10.15252/embr.202255643}
}
Kostenlos starten →